It was part of a 3m sale of two drugs stocks by the UK's biggest quoted venture investor, as MDY snapped up 1.2% of ProStrakan at 61.5p a share, Thursday's closing price. The shares, which doubled to top 100p between March and August last year, firmed ...


Recent comments
6 years 4 weeks ago
15 years 21 weeks ago
15 years 22 weeks ago
15 years 22 weeks ago
15 years 39 weeks ago
15 years 39 weeks ago
15 years 46 weeks ago
16 years 11 weeks ago
16 years 46 weeks ago
16 years 46 weeks ago